This brand name is authorized in Ecuador, Poland
The drug ISMIGEN contains one active pharmaceutical ingredient (API):
| 1 Bacterial lysates |
|
Bacterial lysates are powerful inducers of a specific locoregional immune response that significantly enhance the concentration of antibodies directed to antigenic structures of bacteria most commonly observed during infections of the upper respiratory tract. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07AX | Other bacterial vaccines | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 29491-11-10 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100211120, 100344765, 100355088, 100358454, 100368056, 100372112 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
